Mifamurtide in Metastatic and Recurrent Osteosarcoma: A Patient Access Study with Pharmacokinetic, Pharmacodynamic, and Safety Assessments

PURPOSE: This non-randomized, patient-access protocol, assessed both safety and efficacy outcomes following liposomal muramyl –tripeptide-phosphatidylethanolamine (L-MTP-PE; mifamurtide) in patients with high-risk, recurrent and/or metastatic osteosarcoma. METHODS: Patients received mifamurtide 2 mg...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pediatr Blood Cancer
Main Authors: Anderson, P.M., Meyers, P., Kleinerman, E., Venkatakrishnan, K., Hughes, D.P., Herzog, C., Huh, W., Sutphin, R., Vyas, Y. M., Shen, V., Warwick, A., Yeager, N., Oliva, C., Wang, B., Liu, Y., Chou, A.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533988/
https://ncbi.nlm.nih.gov/pubmed/23997016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24686
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki